Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 4/20 | 0.53 |
| ▸ | CCR8 | P51685 | 4/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | CCR5 | P51681 | 2/20 | 0.48 |
| ▸ | MMP2 | P08253 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | NQO2 | P16083 | 2/20 | 0.48 |
| ▸ | GMNN | O75496 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | MMP9 | P14780 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31036114 | 1.00 | CCR1 (0.53) | CCR1CCR8L3MBTL1LMNAALDH1A1 | |
| SCHEMBL13286604 | 0.91 | DHFR (0.53) | CCR1CCR8L3MBTL1LMNAALDH1A1 | |
| SCHEMBL30022928 | 0.91 | DHFR (0.53) | CCR1CCR8L3MBTL1LMNAALDH1A1 | |
| SCHEMBL30185058 | 0.85 | L3MBTL1 (0.54) | CCR1CCR8L3MBTL1LMNAALDH1A1 | |
| SCHEMBL166826 | 0.85 | L3MBTL1 (0.54) | CCR1CCR8L3MBTL1LMNAALDH1A1 | |
| SCHEMBL29390114 | 0.85 | L3MBTL1 (0.54) | CCR1CCR8L3MBTL1LMNAALDH1A1 | |
| SCHEMBL30185055 | 0.85 | L3MBTL1 (0.54) | CCR1CCR8L3MBTL1LMNAALDH1A1 | |
| SCHEMBL21298335 | 0.84 | CYP3A4 (0.50) | CCR1CCR8L3MBTL1LMNAALDH1A1 | |
| SCHEMBL19443841 | 0.83 | NQO2 (0.41) | CCR1CCR8L3MBTL1LMNAALDH1A1 | |
| Hydrochloric Acid SCHEMBL5931379 | 0.83 | L3MBTL1 (0.52) | CCR1CCR8L3MBTL1LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009080482-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING OCTAHEDRAL METAL (III) POLYPYRIDYL COMPLEXES AND THEIR USE IN PREVENTION AND TREATMENT OF CANCER | FREIE UNIVERSITÄT BERLIN (DE) | 2009-07-02 | — | — | WO | claimed |
| EP-2072521-A1 | Octahedral metal (III) polypyridyl complexes and their use in prevention and treatment of cancer | Freie Universität Berlin (DE) | 2009-06-24 | — | — | EP | claimed |
| US-12311190-B2 | Apparatus and method for irradiating inside an object | Theralase Technologies Inc. (CA) | 2025-05-27 | — | — | US | disclosed |
| WO-2024105603-A1 | A RUTHENIUM (II) POLYPYRIDYL COMPLEX AS A PHOTO-SENSITISER IN PHOTODYNAMIC THERAPY, AND A PROCEDURE FOR MAKING SAID RUTHENIUM (II) POLYPYRIDYL COMPLEX | UNIVERSITÀ DEGLI STUDI DI FIRENZE (IT) | 2024-05-23 | — | — | WO | disclosed |
| US-20220363984-A1 | PHOTO-RESPONSIVE COORDINATION COMPOUNDS WITH PHOTO-CONTROLLABLE ELECTRON-TRANSPORTING AND ELECTRICAL CONDUCTING PROPERTIES, AND FABRICATION OF ORGANIC ELECTRONICS AND ORGANIC RESISTIVE MEMORY DEVICES WITH PHOTO-SWITCHABLE PERFORMANCE | THE UNIVERSITY OF HONG KONG (CN) | 2022-11-17 | — | — | US | disclosed |
| US-20220062654-A1 | APPARATUS AND METHOD FOR IRRADIATING INSIDE AN OBJECT | Theralase Technologies Inc. (CA) | 2022-03-03 | — | — | US | disclosed |
| EP-2976347-B1 | METAL-BASED COORDINATION COMPLEXES AS PHOTODYNAMIC COMPOUNDS AND THEIR USE | MCFARLAND SHERRI ANN (US) | 2022-01-19 | — | — | EP | disclosed |
| US-10781226-B2 | Photoactivatable cancer prodrug | TEXAS STATE UNIVERSITY (US) | 2020-09-22 | — | — | US | disclosed |
| US-10766915-B2 | Metal-based coordination complexes as photodynamic compounds and their use | MCFARLAND SHERRI ANN (CA) | 2020-09-08 | — | — | US | disclosed |
| US-20200239503-A1 | PHOTOACTIVATABLE CANCER PRODRUG | TEXAS STATE UNIVERSITY | 2020-07-30 | — | — | US | disclosed |
| US-10335608-B2 | Photodynamic compounds and methods for activating them using ionizing radiation and/or other electromagnetic radiation for therapy and/or diagnostics | THERALASE TECHNOLOGIES, INC. (CA) | 2019-07-02 | — | — | US | disclosed |
| US-20140148425-A1 | LIGHT INDUCED DRUG RELEASE | UNIVERSITEIT LEIDEN (NL) | 2014-05-29 | — | — | US | disclosed |
| US-20140148425-A1 | LIGHT INDUCED DRUG RELEASE | UNIVERSITEIT LEIDEN (NL) | 2014-05-29 | — | — | US | disclosed |
| US-8372977-B2 | Luminescent gold(III) compounds containing bidentate ligand for organic light-emitting devices and their preparation | THE UNIVERSITY OF HONG KONG (CN) | 2013-02-12 | — | — | US | disclosed |
| WO-2012052821-A1 | LIGHT INDUCED DRUG RELEASE | UNIVERSITEIT LEIDEN (NL) | 2012-04-26 | — | — | WO | disclosed |
| US-20110012093-A1 | LUMINESCENT GOLD(III) COMPOUNDS CONTAINING BIDENTATE LIGAND FOR ORGANIC LIGHT-EMITTING DEVICES AND THEIR PREPARATION | THE UNIVERSITY OF HONG KONG (CN) | 2011-01-20 | — | — | US | disclosed |
| WO-2009080482-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING OCTAHEDRAL METAL (III) POLYPYRIDYL COMPLEXES AND THEIR USE IN PREVENTION AND TREATMENT OF CANCER | FREIE UNIVERSITÄT BERLIN (DE) | 2009-07-02 | — | — | WO | disclosed |
| EP-2072521-A1 | Octahedral metal (III) polypyridyl complexes and their use in prevention and treatment of cancer | Freie Universität Berlin (DE) | 2009-06-24 | — | — | EP | disclosed |
| EP-2072521-A1 | Octahedral metal (III) polypyridyl complexes and their use in prevention and treatment of cancer | Freie Universität Berlin (DE) | 2009-06-24 | — | — | EP | disclosed |
| EP-1019401-B1 | COMPLEX COMPRISING A RARE-EARTH METAL ION AND A COMPLEXING MOIETY | KONINKL PHILIPS ELECTRONICS NV (NL) | 2008-01-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140148425-A1 | LIGHT INDUCED DRUG RELEASE | IK, MC1R, SUCNR1 | CCR1 4209/4885CCR8 4618/4885L3MBTL1 1626/4885 |
| US-10781226-B2 | Photoactivatable cancer prodrug | UGT1A7, DCPS, PPOX | CCR1 4203/4885CCR8 2921/4885L3MBTL1 1939/4885 |
| US-20220363984-A1 | PHOTO-RESPONSIVE COORDINATION COMPOUNDS WITH PHOTO-CONTROLLABLE ELECTRON-TRANSPORTING AND ELECTRICAL CONDUCTING PROPERTIES, AND FABRICATION OF ORGANIC ELECTRONICS AND ORGANIC RESISTIVE MEMORY DEVICES WITH PHOTO-SWITCHABLE PERFORMANCE | L1CAM, SLC1A2, CLTB | CCR1 2213/4885CCR8 2934/4885L3MBTL1 2990/4885 |
| US-10766915-B2 | Metal-based coordination complexes as photodynamic compounds and their use | PIN1, PPIF, PPOX | CCR1 675/4885CCR8 2303/4885L3MBTL1 2181/4885 |
| US-10335608-B2 | Photodynamic compounds and methods for activating them using ionizing radiation and/or other electromagnetic radiation for therapy and/or diagnostics | PPOX, HMBS, XPA | CCR1 4695/4885CCR8 4662/4885L3MBTL1 3037/4885 |
| US-20110012093-A1 | LUMINESCENT GOLD(III) COMPOUNDS CONTAINING BIDENTATE LIGAND FOR ORGANIC LIGHT-EMITTING DEVICES AND THEIR PREPARATION | CHRM1, CHRM5, CHRM2 | CCR1 741/4885CCR8 562/4885L3MBTL1 30/4885 |
| US-20200239503-A1 | PHOTOACTIVATABLE CANCER PRODRUG | UGT1A7, DCPS, PPOX | CCR1 4203/4885CCR8 2921/4885L3MBTL1 1939/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.